肝动脉灌注化学治疗中晚期肝癌进展  

Progress of hepatic artery infusion chemotherapy of advanced hepatocellular carcinoma

作　　者：刘少兴 朱旭[1] LIU Shaoxing;ZHU Xu(Department of Interventional Therapy,Peking University Cancer Hospital and Institute,Beijing 100142,China)

机构地区：[1]北京大学肿瘤医院介入科,北京100142

出　　处：《中国介入影像与治疗学》2020年第10期632-635,共4页Chinese Journal of Interventional Imaging and Therapy

基　　金：国家自然科学基金(91971717);北京市科技委项目(Z181100010118001)。

摘　　要：中晚期原发性肝癌的介入治疗方法不断发展,其中肝动脉灌注化学治疗(简称化疗)效果显著。随着化疗药物更新及配伍方式优化,对中晚期肝癌行肝动脉灌注化疗的临床研究及应用逐渐增多。本文对中晚期肝癌肝动脉灌注化疗主要药物及临床研究进展进行综述。Interventional therapy of advanced hepatocellular carcinoma(HCC)was constantly developing,and hepatic artery infusion chemotherapy(HAIC)had present significant therapeutic effect.With the update of chemotherapy drugs and compatibility,clinical research and application of HAIC for advanced HCC increased gradually.The main drugs and clinical progress of HAIC for advanced HCC were reviewed in this article.

关 键 词：肝肿瘤 肝动脉 化学治疗 肿瘤 局部灌注 

分 类 号：R735.7[医药卫生—肿瘤] R815[医药卫生—临床医学]